DLBCL Transformed From Indolent Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00441Gemcitabine3Completed1
DB06193Pixantrone3Completed1
DB00073Rituximab3Completed1